SCHEMBL2841252

SCHEMBL2841252

NOC(=O)CCO

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2477030 0.97
SCHEMBL468549 0.83 TSHR (0.44)
SCHEMBL11046376 0.82
Methacrylic Acid SCHEMBL29556130 0.82 TDP1 (0.33)
SCHEMBL7536494 0.80
SCHEMBL275122 0.78 TSHR (0.43)
SCHEMBL1060951 0.78 TSHR (0.50)
SCHEMBL1064431 0.75 DGKA (0.42)
SCHEMBL9593894 0.75 DGKA (0.42)
SCHEMBL2180897 0.75 DGKA (0.42)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 28 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250387771-A1 COMPOSITION COMPRISING BIODEGRADABLE MICROCAPSULES GIVAUDAN SA (CH) 2025-12-25 US claimed
EP-4557951-A1 COMPOSITION COMPRISING BIODEGRADABLE MICROCAPSULES Givaudan SA (CH) 2025-05-28 EP claimed
WO-2024017931-A1 COMPOSITION COMPRISING BIODEGRADABLE MICROCAPSULES GIVAUDAN SA (CH) 2024-01-25 WO claimed
EP-4309499-A1 COMPOSITION COMPRISING BIODEGRADABLE MICROCAPSULES Givaudan SA (CH) 2024-01-24 EP claimed
US-11459501-B2 Chelating acid blends for stimulation of a subterranean formation, methods of utilizing the chelating acid blends, and hydrocarbon wells that include the chelating acid blends EXXONMOBIL UPSTREAM RESEARCH COMPANY (US) 2022-10-04 US claimed
US-20210324260-A1 CHELATING ACID BLENDS FOR STIMULATION OF A SUBTERRANEAN FORMATION, METHODS OF UTILIZING THE CHELATING ACID BLENDS, AND HYDROCARBON WELLS THAT INCLUDE THE CHELATING ACID BLENDS EXXONMOBIL UPSTREAM RES CO (US) 2021-10-21 US claimed
EP-1259512-B1 PTERIDINE COMPOUNDS FOR THE TREATMENT OF PSORIASIS ASTRAZENECA AB (SE) 2003-09-24 EP claimed
US-20250387771-A1 COMPOSITION COMPRISING BIODEGRADABLE MICROCAPSULES GIVAUDAN SA (CH) 2025-12-25 US disclosed
EP-4557951-A1 COMPOSITION COMPRISING BIODEGRADABLE MICROCAPSULES Givaudan SA (CH) 2025-05-28 EP disclosed
US-20240271028-A1 METHODS FOR PREVENTING OR MITIGATING WELLBORE SCREEN OUT CONDITIONS USING ACID BLENDS EXXONMOBIL TECHNOLOGY & ENGINEERING COMPANY (US) 2024-08-15 US disclosed
EP-4352183-A1 METHODS FOR PREVENTING OR MITIGATING WELLBORE SCREEN OUT CONDITIONS USING ACID BLENDS ExxonMobil Technology and Engineering Company (US) 2024-04-17 EP disclosed
WO-2024017931-A1 COMPOSITION COMPRISING BIODEGRADABLE MICROCAPSULES GIVAUDAN SA (CH) 2024-01-25 WO disclosed
EP-4309499-A1 COMPOSITION COMPRISING BIODEGRADABLE MICROCAPSULES Givaudan SA (CH) 2024-01-24 EP disclosed
CN-104981458-B Inhibitors of histone demethylases 吉利德科学公司 2017-07-21 CN disclosed
EP-2401225-B1 A SUPRAMOLECULAR APPROACH FOR PREPARATION OF SIZE CONTROLLABLE NANOPARTICLES UNIV CALIFORNIA (US) 2014-10-22 EP disclosed
US-20110171163-A1 POLYMER CONJUGATES OF ZICONOTIDE PEPTIDES NEKTAR THERAPEUTICS (US) 2011-07-14 US disclosed
US-20110165112-A1 POLYMER CONJUGATES OF C-PEPTIDES NEKTAR THERAPEUTICS (US) 2011-07-07 US disclosed
EP-2195328-A1 CERTAIN CHEMICAL ENTITIES, COMPOSITIONS, AND METHODS Cytokinetics, Incorporated (US) 2010-06-16 EP disclosed
CN-101528658-A Method for producing acrylic acid purified by crystallization from hydroxypropionic acid and apparatus therefor STOCKHAUSEN CHEM FAB GMBH (DE) 2009-09-09 CN disclosed
WO-2009023193-A1 CERTAIN CHEMICAL ENTITIES, COMPOSITIONS, AND METHODS CYTOKINETICS, INCORPORATED (US) 2009-02-19 WO disclosed